Angelo Ghirarduzzi

Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome

Vittorio Pengo, Gentian Denas, Giacomo Zoppellaro et al. · Blood · 2018 · 798 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients

Paolo Prandoni, Franco Noventa, Angelo Ghirarduzzi et al. · Haematologica · 2007 · 770 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

<scp>d</scp> -Dimer Testing to Determine the Duration of Anticoagulation Therapy

Gualtiero Palareti, Benilde Cosmi, Cristina Legnani et al. · New England Journal of Medicine · 2006 · 623 citations

Medicine, Hematology, Internal Medicine +17

Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis

Giancarlo Agnelli, Paolo Prandoni, Maria Gabriella Santamaria et al. · New England Journal of Medicine · 2001 · 592 citations · Full text

Medicine, Hematology, Pharmacotherapy +15

Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study

Vittorio Pengo, Amelia Ruffatti, Cristina Legnani et al. · Blood · 2011 · 459 citations · Full text

Medicine, Hematology, Immunology +15